Predictors of dose limiting toxicities in phase I clinical trials: The impact of age, comorbidity, and other clinical and non-clinical factors

Authors :: J. Bozeman
Noelle K. LoConte
Kyle D. Holen
Jinn-Ing Liou
Maureen A. Smith
D. Alberti
George Wilding
James F. Cleary
A. Setala
Source :: Journal of Clinical Oncology. 26:9525-9525
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 9525 Background: There are no clear predictors clinicians use to predict dose limiting toxicity (DLT) in phase I chemotherapy clinical trials. Many providers are reluctant to refer older adults to ...

Subjects :: Oncology
Cancer Research
Chemotherapy
medicine.medical_specialty
Dose limiting toxicity
business.industry
medicine.medical_treatment
Pharmacology
medicine.disease
Comorbidity
Clinical trial
Non clinical
Internal medicine
medicine
business

Full Text Access

Tools